In Cell & Gene Therapy (CGT), long-term T cell stability directly affects process robustness, batch consistency, and downstream efficacy.
CS-DX-N2, a DMSO-free cryopreservation medium from CellStore Biotech, was evaluated under long-term storage conditions:
Long-term stability (1, 3, 6 months)
Viability: 90.6%–92.7%
Recovery: 89.5%–90.9%
Consistently outperforming benchmark products.
Batch-to-batch consistency
Independent lots achieved recovery rates up to 96%, approaching fresh T cell performance—minimizing variability in CGT workflows.
High-density cryopreservation
Validated at 8 × 10⁶ cells/mL, enabling higher storage efficiency without compromising cell quality.
With a DMSO-free formulation and data-backed performance, CS-DX-N2 is designed for CGT teams who prioritize safety, reproducibility, and scalability.
Learn more CS-DX-N2, Contact us.
